Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis

The clinical benefit and potential risks of conversion surgery after neoadjuvant chemotherapy (NACT) have not been fully investigated in patients with borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). Therefore, this has been evaluated in a re...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cancers (Basel)
Główni autorzy: Yoo, Changhoon, Shin, Sang Hyun, Kim, Kyu-pyo, Jeong, Jae Ho, Chang, Heung-Moon, Kang, Jun Ho, Lee, Sang Soo, Park, Do Hyun, Song, Tae Jun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Park, Jin-hong, Hwang, Dae Wook, Song, Ki Byung, Lee, Jae Hoon, Ryoo, Baek-Yeol, Kim, Song Cheol
Format: Artigo
Język:Inglês
Wydane: MDPI 2019
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6468804/
https://ncbi.nlm.nih.gov/pubmed/30813624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11030278
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy